Some genetic-level CDH1 alterations include inactivating mutations and loss of heterozygosity (LOH), found in infiltrating lobular breast carcinomas, and heterozygous germline mutations that increase the lifetime risk of developing diffuse gastric cancer and lobular breast cancer. Here, CDH1 is linked to invasive lobular breast carcinoma.